TY - JOUR
T1 - Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: results from randomised trial.
JO - Br J Cancer
UR - http://eprints.whiterose.ac.uk/95934/
PY - 2006/02/27
AU - Dixon S
AU - Walters SJ
AU - Turner L
AU - Hancock BW
ED -
DO - DOI: 10.1038/sj.bjc.6602973
VL - 94
IS - 4
SP - 492
EP - 498
Y2 - 2025/05/29
ER -